Cargando…
Post‐marketing dosing changes in the label of biologicals
AIM: The aim of this study was to evaluate post‐marketing label changes in dosing information of biologicals. METHODS: Biologicals authorized between 2007 and 2014 by the European Medicines Agency (EMA) were included and followed up from marketing authorization until 31 December 2016 or date of with...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422665/ https://www.ncbi.nlm.nih.gov/pubmed/30593087 http://dx.doi.org/10.1111/bcp.13843 |